The Keller Army Community Hospital Division I Sports Physical Therapy Fellowship Project #13 Team was the first team within the Musculoskeletal Injury Rehabilitation Research for Operational Readiness (MIRROR) group at the Uniformed Services University to enroll a...
Lotus Clinical Research has a clinical trial testing its non-opioid pain medication called CA-008 during an elective unilateral transpositional first metatarsal osteotomy for the correction of hallux valgus deformity (bunionectomy), also known as bunion surgery....
New York University partnered with an international research team to study the use of nanoparticles to deliver a non-opioid-based drug—one that previously failed in clinical trials for pain—into specific compartments of nerve cells, dramatically increasing its ability...
Streetinsider reports Medtronic plc (NYSE: MDT) today announced the first patient enrolled in the Embrace TDD (targeted drug delivery) clinical study that will evaluate the use of the SynchroMed(TM) II intrathecal drug delivery system (“Medtronic pain...
Paul Gaita for The Fix writes that commercial sponsor and investigators hope that a non-opioid treatment for back pain will be approved by the FDA so it will be eligible for Medicare and Medicaid coverage. The opioid crisis rages on ravaging communities and...
As released on the BusinessWire, “Concentric Analgesics, Inc., a clinical-stage biopharmaceutical pain company, announced today that it has initiated a Phase 2 clinical study of CA-008, the Company’s lead product candidate for the treatment of post-surgical pain....
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
